Abacavir
NDC 31722-562, Abacavir, solution, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-562
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201107
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-562 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABACAVIR SULFATE20 mg/mL
Pharmacologic classes
Cytochrome P450 1A1 Inhibitors [MoA]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-562-24 | 31722056224 | 240 mL in 1 BOTTLE (31722-562-24) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e5cbf204-c10d-444b-aba0-180a30645d55
Use it
Look up 31722-562 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-562 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-562. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.